159 related articles for article (PubMed ID: 20303520)
1. The EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer.
Perez CA; Chen H; Shyr Y; Courtney R; Zheng W; Cai Q; Hwang M; Jaboin J; Schleicher S; Moretti L; Wills M; Smith JA; Lu B
J Urol; 2010 May; 183(5):2062-9. PubMed ID: 20303520
[TBL] [Abstract][Full Text] [Related]
2. The matrix metalloproteinase-7 polymorphism rs10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer.
Jaboin JJ; Hwang M; Lopater Z; Chen H; Ray GL; Perez C; Cai Q; Wills ML; Lu B
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1330-5. PubMed ID: 20605361
[TBL] [Abstract][Full Text] [Related]
3. Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer.
Bañez LL; Sun L; van Leenders GJ; Wheeler TM; Bangma CH; Freedland SJ; Ittmann MM; Lark AL; Madden JF; Hartman A; Weiss G; Castaños-Vélez E
J Urol; 2010 Jul; 184(1):149-56. PubMed ID: 20478579
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.
Huang SP; Huang LC; Ting WC; Chen LM; Chang TY; Lu TL; Lan YH; Liu CC; Yang WH; Lee HZ; Hsieh CJ; Bao BY
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3068-74. PubMed ID: 19900942
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Prostaglandin-endoperoxide Synthase 2 Polymorphisms in Prostate Cancer Recurrence after Radical Prostatectomy.
Lee CH; Pao JB; Lu TL; Lee HZ; Lee YC; Liu CC; Huang CY; Lin VC; Yu CC; Yin HL; Huang SP; Bao BY
Int J Med Sci; 2016; 13(9):696-700. PubMed ID: 27647999
[TBL] [Abstract][Full Text] [Related]
6. Influence of cytokine gene polymorphisms on prostate-specific antigen recurrence in prostate cancer after radical prostatectomy.
Lin HC; Liu CC; Kang WY; Yu CC; Wu TT; Wang JS; Wu WJ; Huang CH; Wu MT; Huang SP
Urol Int; 2009; 83(4):463-70. PubMed ID: 19996656
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide detection of allelic genetic variation to predict biochemical recurrence after radical prostatectomy among prostate cancer patients using an exome SNP chip.
Oh JJ; Park S; Lee SE; Hong SK; Lee S; Lee HM; Lee JK; Ho JN; Yoon S; Byun SS
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1493-501. PubMed ID: 25764380
[TBL] [Abstract][Full Text] [Related]
8. Genetic predisposition to early recurrence in clinically localized prostate cancer.
Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants of the CYP1B1 gene as predictors of biochemical recurrence after radical prostatectomy in localized prostate cancer patients.
Gu CY; Qin XJ; Qu YY; Zhu Y; Wan FN; Zhang GM; Sun LJ; Zhu Y; Ye DW
Medicine (Baltimore); 2016 Jul; 95(27):e4066. PubMed ID: 27399092
[TBL] [Abstract][Full Text] [Related]
10. Cancer Stem Cell Gene Variants Predict Disease Recurrence in Patients Treated with Radical Prostatectomy for Prostate Cancer.
Lin VC; Huang SP; Huang CY; Yu CC; Yin HL; Huang TY; Lee CH; Lu TL; Bao BY
Int J Med Sci; 2017; 14(12):1301-1306. PubMed ID: 29104488
[No Abstract] [Full Text] [Related]
11. Prognostic significance of cyclin D1 polymorphisms on prostate-specific antigen recurrence after radical prostatectomy.
Yu CC; Lin VC; Huang CY; Liu CC; Wang JS; Wu TT; Pu YS; Huang CH; Huang CN; Huang SP; Bao BY
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S492-9. PubMed ID: 23354566
[TBL] [Abstract][Full Text] [Related]
12. Effect of genetic variants in cell adhesion pathways on the biochemical recurrence in prostate cancer patients with radical prostatectomy.
Yu CC; Chen LC; Lin VC; Huang CY; Cheng WC; Hsieh AR; Chang TY; Lu TL; Lee CH; Huang SP; Bao BY
Cancer Med; 2019 Jun; 8(6):2777-2783. PubMed ID: 30993852
[TBL] [Abstract][Full Text] [Related]
13. Association analysis of Wnt pathway genes on prostate-specific antigen recurrence after radical prostatectomy.
Huang SP; Ting WC; Chen LM; Huang LC; Liu CC; Chen CW; Hsieh CJ; Yang WH; Chang TY; Lee HZ; Bao BY
Ann Surg Oncol; 2010 Jan; 17(1):312-22. PubMed ID: 19777185
[TBL] [Abstract][Full Text] [Related]
14. p53 codon 72 increased biochemical recurrence risk after radical prostatectomy in a southern Chinese population.
Xu B; Mi YY; Min ZC; Cheng G; Tong N; Tao J; Li PC; Wang ML; Tang JL; Zhang ZD; Song NH; Zhang W; Wu HF; Feng NH; Hua LX
Urol Int; 2010; 85(4):401-5. PubMed ID: 20664183
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Relevance of Methylenetetrahydrofolate Reductase Polymorphisms for Prostate Cancer.
Lin VC; Lu TL; Yin HL; Yang SF; Lee YC; Liu CC; Huang CY; Yu CC; Chang TY; Huang SP; Bao BY
Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916838
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomy.
Huang SP; Huang CY; Wang JS; Liu CC; Pu YS; Yu HJ; Yu CC; Wu TT; Huang CH; Wu WJ; Chou YH; Wu MT
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6632-8. PubMed ID: 18006764
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
Rosenbaum E; Hoque MO; Cohen Y; Zahurak M; Eisenberger MA; Epstein JI; Partin AW; Sidransky D
Clin Cancer Res; 2005 Dec; 11(23):8321-5. PubMed ID: 16322291
[TBL] [Abstract][Full Text] [Related]
18. Improved prediction of biochemical recurrence after radical prostatectomy by genetic polymorphisms.
Morote J; Del Amo J; Borque A; Ars E; Hernández C; Herranz F; Arruza A; Llarena R; Planas J; Viso MJ; Palou J; Raventós CX; Tejedor D; Artieda M; Simón L; Martínez A; Rioja LA
J Urol; 2010 Aug; 184(2):506-11. PubMed ID: 20620409
[TBL] [Abstract][Full Text] [Related]
19. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
Han M; Partin AW; Zahurak M; Piantadosi S; Epstein JI; Walsh PC
J Urol; 2003 Feb; 169(2):517-23. PubMed ID: 12544300
[TBL] [Abstract][Full Text] [Related]
20. Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer.
Fukuda H; Tsuchiya N; Narita S; Kumazawa T; Horikawa Y; Inoue T; Saito M; Yuasa T; Matsuura S; Satoh S; Ogawa O; Habuchi T
Oncol Rep; 2007 Nov; 18(5):1155-63. PubMed ID: 17914566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]